Ontology highlight
ABSTRACT: Importance
Evidence-based, patient-centered treatment for alcohol use disorder (AUD) can include pharmacotherapy with naltrexone, acamprosate, or disulfiram; however, these medications are rarely used. Medicaid managed care plans (MCPs) manage health services for nearly 80% of Medicaid enrollees and are the largest payer for addiction treatment services. Little is known about Medicaid MCP policies for AUD medications.Objectives
To describe Medicaid MCPs' coverage and management of acamprosate, naltrexone, and disulfiram for AUD and examine associations of plan characteristics and state policies with medication coverage.Design, setting, and participants
In this cross-sectional study, a content analysis was performed of 2021 insurance benefit data for 241 comprehensiv
SUBMITTER: Stewart MT
PROVIDER: S-EPMC11907321 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature